alexa
Reach Us +441467840001
Editor - Joydip Das | Department of Pharmacological and Pharmace | 297
ISSN: 2161-0444

Medicinal Chemistry
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Joydip Das

Joydip Das
Joydip Das
Associate Professor
Department of Pharmacological and Pharmaceutical Sciences
University of Houston
USA

Biography

Dr. Das Joydip is an Assistant Professor of Medicinal Chemistry at the Department of Pharmacological and Pharmaceutical Sciences University of Houston. He received his Ph.D in Bioorganic Chemistry from the Indian Institute of Technology Bombay and got post doctoral training at the Medical University of South Carolina Massachusetts Institute of Technology and Massachusetts General Hospital/Harvard Medical School. His research articles have been published in Biochemistry J Biol Chem, Protein Sci Biochem J, J Am Chem Soc Bioorg Med Chem Lett etc.

Research Interest

The major focus of his research has been the ligand-protein interaction in soluble and membrane proteins, role of protein kinase Cs in modulating alcohol actions and developing isotype-specific modulator for this family of proteins. Protein biochemistry, Mass spectrometry, X-ray crystallography and organic synthesis are used for this research.

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Protein Kinase C: The Drug Target One Must See

Joydip Das
Editorial: Med Chem (Los Angeles) 2012, 2:e103
DOI: 10.4172/2161-0444.1000e103
Top